Swallowing Assessment Protocols for Aspiration in Respiratory Failure Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand swallowing issues that could develop in patients who have been critically ill and required mechanical ventilation. Researchers are testing various methods to assess swallowing, including a tracheal ultrasound (a scan of the windpipe), three screening tests (3-Screenings Protocol), and a fiberoptic endoscopic exam (a camera check of swallowing, also known as FEES). The trial seeks participants who were in an ICU and used a breathing tube for more than two days but have no history of swallowing problems. As an unphased trial, it offers a unique opportunity to contribute to research that could improve care for future patients with similar experiences.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these swallowing assessment protocols are safe for respiratory failure survivors?
Research has shown that the 3-Screenings Protocol, which includes the 3-ounce water swallow test and the TOR-BSST, is generally safe for patients. The 3-ounce water swallow test, used in many studies, effectively identifies swallowing problems without causing harm.
Studies have demonstrated that FEES (Fiberoptic Endoscopic Evaluation of Swallowing) reliably checks swallowing. While mostly safe, some patients might face a slightly higher risk of conditions like pneumonia if food or liquid enters the airway during the test. However, the procedure itself remains effective and safe for assessing swallowing issues.
Tracheal ultrasound is another safe and non-invasive method. It has been used to monitor patients with breathing problems and guides treatments without major safety concerns reported in previous studies.
Overall, these assessments are well-tolerated, with minimal side effects, making them relatively safe options for evaluating swallowing issues in patients recovering from respiratory failure.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to assess swallowing difficulties in patients recovering from respiratory failure. Unlike traditional methods that might rely solely on clinical observation or subjective assessments, this trial uses a combination of advanced techniques like tracheal ultrasound and fiberoptic endoscopic examination of swallowing (FEES). These methods can provide real-time, detailed insights into a patient’s swallowing function, potentially allowing for more accurate diagnoses and tailored interventions. By integrating these screenings, the trial aims to enhance the early detection of aspiration risk, which could lead to better outcomes and faster recovery for patients.
What evidence suggests that these swallowing assessment protocols are effective for aspiration in respiratory failure survivors?
In this trial, all participants will receive a tracheal ultrasound, a newer method using sound waves to examine the throat. This technique has shown promise in identifying swallowing issues, helping ensure safer eating and drinking for those with such problems and reducing the risk of aspiration. Additionally, the trial employs the 3-Screenings Protocol, which includes tests like the 3-ounce water swallow test and the TOR-BSST, to effectively identify swallowing issues. The 3-ounce water swallow test predicts who might accidentally inhale food or liquid into their lungs, known as aspiration. The TOR-BSST highlights a higher risk of swallowing problems if any part of the test is not passed. Participants will also undergo FEES (fiberoptic endoscopic evaluation of swallowing), a respected method known for accurately detecting aspiration in patients with sudden breathing problems.12367
Who Is on the Research Team?
Marc Moss, MD
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
This trial is for adults who've been in the ICU and on a ventilator for over 48 hours. It's not suitable for those with uncontrolled bleeding, persistent delirium after extubation, neuromuscular disorders, chronic tracheostomy before ICU admission, head and neck cancer or surgery history, under 18s, prior swallowing issues or aspiration history.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Extubation Assessment
Participants receive a tracheal ultrasound within 72 hours prior to extubation and collection of demographic and hospital clinical information
Post-Extubation Assessment
Administration of 3 screening tests addressing swallowing function within 24 hours post-extubation and a fiberoptic endoscopic examination of swallowing (FEES) exam
Follow-up
Participants are monitored for post-extubation dysphagia and aspiration from extubation day 1 through hospital discharge
What Are the Treatments Tested in This Trial?
Interventions
- 3-Screenings Protocol
- FEES
- Tracheal Ultrasound
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator